Avantor Expands St. Louis Site with GMP-Aligned Microbial Testing, ICH Stability
Avantor expanded its St. Louis manufacturing site to add GMP-aligned microbial testing and ICH-compliant stability testing, supporting over 2,000 samples annually. The consolidation of outsourced testing into an audit-ready facility boosts turnaround times, data visibility, and supply chain efficiency for U.S.-based biopharma operations.
1. Facility Expansion Details
Avantor expanded its St. Louis manufacturing site with GMP-aligned microbial testing and ICH-compliant stability testing, supporting over 2,000 microbial samples annually.
2. Operational Benefits
The integrated facility consolidates previously outsourced testing, reduces cross-border sample movement, accelerates turnaround times, and improves data visibility, simplifying supply chain operations for U.S. biopharma customers.
3. Strategic Investment and Revival Program
As part of the Revival program, Avantor invested in enhanced North American quality infrastructure to strengthen manufacturing support, reduce supply chain complexity, and deliver high-value chemicals and services faster.
4. Compliance and Market Impact
The audit-ready labs and advanced storage capabilities for APIs and excipients support global regulatory compliance and may enhance Avantor’s competitive position in the biomanufacturing sector.